The burden associated with, and management of, difficult-to-treat depression in patients under specialist psychiatric care in the United Kingdom
Open accessThe DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Abstract
Background: Major depressive disorder (MDD) is common and often has sub-optimal response to treatment. Difficult-to-treat depression (DTD) is a new concept that describes ‘depression that continues to cause significant burden despite usual treatment efforts’. Aims: To identify patients with likely DTD in UK secondary care and examine demographic, disease and treatment data as compared with ‘non-DTD’ MDD patients. Methods: Anonymised electronic health records (EHRs) of five specialist mental health National Health Service (NHS) Trusts in the United Kingdom were analysed using a natural language processing model. Data on disease characteristics, comorbidities and treatment histories were extracted from structured fields and using natural language algorithms from unstructured fields. Patients with MDD aged ⩾18 years were included in the analysis; those with presumed DTD were identified on the basis of MDD history (duration and recurrence) and number of treatments prescribed. Results: In a sample of 28,184 patients with MDD, 19% met criteria for DTD. Compared to the non-DTD group, patients with DTD were more likely to have severe depression, suicidal ideation, and comorbid psychiatric and/or physical illness, as well as higher rates of hospitalisation. They were also more likely to be in receipt of unemployment and sickness/disability benefits. More intensive treatment strategies were used in the DTD group, including higher rates of combination therapy, augmentation, psychotherapy and electroconvulsive therapy. Conclusion: This study demonstrates the feasibility of identifying patients with probable DTD from EHRs and highlights the increased burden associated with MDD in these patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The related, but separate, notion of DTD seems more aligned with the realities of the clinical ecosystem, and with patient experi ence of depression and sequential non- re sponse to treatments 94,286 .”
From Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions (2023) · cites this paper as [286]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MIMIC-III, a freely accessible critical care database
Johnson, A. E. W., Pollard, T. J., Shen, L., Lehman, L.-W. H., Feng, M., Ghassemi, M., Moody, B., Szolovits, P., Anthony Celi, L., & Mark, R. G. (2016) · Scientific Data · doi:10.1038/sdata.2016.35 · Cited by 8,141 · cited 1×
“The Med7 NLP model was originally trained on general physical health data (Johnson et al., 2016), being then fine-tuned on the UK-CRIS EHR data to learn domain knowledge of mental health records (Kormilitzin et al., 2021).”
MethodScoville, W. B. (1949) · Journal of neurosurgery · doi:10.3171/jns.1949.6.1.0065 · Cited by 7,380
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643 · cited 2×
“For those who do not respond, an alternative treatment can be tried, but a significant proportion of patients do not achieve remission despite serial treatments (Rush et al., 2006).”
BackgroundMalhi, G. S., & Mann, J. J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31948-2 · Cited by 4,099
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879 · cited 2×
“In the largest clinical trial ever conducted of what would be consistent with first-line UK treatment of MDD, the selective serotonin reuptake inhibitor (SSRI) citalopram led to around 30% of patients being relatively free of symptoms, that is, in remission (Trivedi et al., 2006).”
BackgroundThe Economic Burden of Adults With Major Depressive Disorder in the United States (2005 and 2010)
Greenberg, P. E., Fournier, A.-A., Sisitsky, T., Pike, C. T., & Kessler, R. C. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09298 · Cited by 1,779 · cited 1×
“The presence of comorbidity is a major driver of the economic burden of MDD, with 62% of total health care costs being due to comorbid conditions rather than MDD itself (Greenberg et al., 2015).”
BackgroundMultimorbidity and depression: A systematic review and meta-analysis
Read, J. R., Sharpe, L., Modini, M., & Dear, B. F. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.06.009 · Cited by 869 · cited 1×
“Conversely, depression is twice as likely in those individuals with multimorbidity than those with only one comorbidity, and three times as likely than those with no comorbidity (Read et al., 2017).”
BackgroundCleare, A., Pariante, C., Young, A., Anderson, I., Christmas, D., Cowen, P., Dickens, C., Ferrier, I., Geddes, J., Gilbody, S., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115581093 · Cited by 759 · cited 6×
“Olanzapine was the next most common augmentation agent, despite only being a second-line recommendation in most guidelines (Cleare et al., 2015; Taylor et al., 2020).”
BackgroundMethodResultInfluentialfor the European Depression in Diabetes (EDID) Research Consortium, Nouwen, A., Winkley, K., Twisk, J., Lloyd, C. E., Peyrot, M., Ismail, K., & Pouwer, F. (2010) · Diabetologia · doi:10.1007/s00125-010-1874-x · Cited by 756 · cited 1×
“It is also frequently comorbid with a range of physical disorders such as type 2 diabetes, asthma, gastrointestinal and musculoskeletal conditions (Gagnon and Patten, 2002; Nouwen et al., 2010).”
Paying the price: the cost of mental health care in England to 2026
McCrone, P., Dhanasiri, S., Patel, A. K., Knapp, M. R. J., & Lawton-Smith, S. H. (2008) · Research Portal (King's College London) · Cited by 577
Research works printed but not linked: 2
- NICE, 2009, Depression in Adults: Treatment and Management – Clinical Guideline [CG90]
- WHO, 2017, Depression and Other Common Mental Disorders: Global Health Estimates
Cited by
McIntyre, R. S., Alsuwaidan, M., Baune, B. T., Berk, M., Demyttenaere, K., Goldberg, J. F., Gorwood, P., Ho, R., Kasper, S., Kennedy, S. H., et al. (2023) · World Psychiatry · doi:10.1002/wps.21120 · Cited by 836
Artificial intelligence-based suicide prevention and prediction: A systematic review (2019–2023)
Atmakuru, A., Shahini, A., Chakraborty, S., Seoni, S., Salvi, M., Hafeez‐Baig, A., Rashid, S., Tan, R., Barua, P. D., Molinari, F., et al. (2024) · Information Fusion · doi:10.1016/j.inffus.2024.102673 · Cited by 49
Pappa, S., Shah, M., Young, S., Anwar, T., & Ming, T. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.11.022 · Cited by 21
Difficult-To-Treat Depression. Scoping Review.
Paganin, W., Signorini, S. G., & Sciarretta, A. (2023) · PubMed Central · doi:10.36131/cnfioritieditore20230302 · Cited by 28
“…NL 16 Riveros et al., 2022 Review Article Antioxidants Switzerland 17 Moeller et al., 2022 Review Article Nordic Journal of Psychiatry UK 18 Sforzini et al., 2022 Review Article Molecular Psychiatry USA 19 Costa et al., 2022 Original Article Journal of Psychopharmacology UK 20 Rosana Silva.”
BackgroundGill, K., Hett, D., Carlish, M., Amos, R., Khatibi, A., Morales‐Muñoz, I., & Marwaha, S. (2025) · The British Journal of Psychiatry · doi:10.1192/bjp.2024.275 · Cited by 17
“10,11 Most research has relied on large cohort studies using electronic health records (EHRs), with few studies having used mixed-methods approaches that include patient and clinician perspectives.”
Metadata
- Authors
- Costa, T., Menzat, B., Engelthaler, T., Fell, B., Franarin, T., Roque, G., Wei, Y., Zhang, X., & McAllister-Williams, R. H.
- Affiliations
- Cumbria Northumberland Tyne and Wear NHS Foundation Trust (GB)
- Akrivia Health, Oxford Centre for Innovation, Oxford, UK
- Northern Centre for Mood Disorders, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2022-05
- Volume
- 36
- Issue
- 5
- Pages
- 545-556
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- PMC
- PMC9112623
- OpenAlex
- W4229030116
- Cited by
- 22
- References
- 38
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 9 · 2023: 2 · 2022: 1
- FWCI
- 2.54
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Psychopharmacology (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- LivaNova (Commissioned and funded the study and analysis)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- difficult-to-treat depression, major depressive disorder, treatment burden, secondary care, comorbidities, suicidal ideation, hospitalization, treatment history, augmentation therapy, electroconvulsive therapy, psychotherapy, natural language processing, electronic health records
- MeSH terms
- Aged, Depression, Major Depressive Disorder, Humans, Psychotherapy, State Medicine, Suicidal Ideation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The burden associated with, and management of, difficult-to-treat depression in patients under specialist psychiatric care in the United Kingdom. https://app.cochat.ai/papers/10.1177/02698811221090628
- The paper
- Costa, T., Menzat, B., Engelthaler, T., Fell, B., Franarin, T., Roque, G., Wei, Y., Zhang, X., & McAllister-Williams, R. H. (2022). The burden associated with, and management of, difficult-to-treat depression in patients under specialist psychiatric care in the United Kingdom. Journal of Psychopharmacology. https://doi.org/10.1177/02698811221090628
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
